These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 10381042

  • 1. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN, Hossain M, Haq SA, Alam MN, Ten Klooster PM, Rasker JJ.
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [Abstract] [Full Text] [Related]

  • 3. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.
    Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
    [Abstract] [Full Text] [Related]

  • 4. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Feb 15; 25(2):243-6. PubMed ID: 9489814
    [Abstract] [Full Text] [Related]

  • 6. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb 15; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar 15; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

  • 8. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
    Bezerra EL, Vilar MJ, da Trindade Neto PB, Sato EI.
    Arthritis Rheum; 2005 Oct 15; 52(10):3073-8. PubMed ID: 16200586
    [Abstract] [Full Text] [Related]

  • 9. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 15; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus.
    Williams HJ, Egger MJ, Singer JZ, Willkens RF, Kalunian KC, Clegg DO, Skosey JL, Brooks RH, Alarcón GS, Steen VD.
    J Rheumatol; 1994 Aug 15; 21(8):1457-62. PubMed ID: 7983646
    [Abstract] [Full Text] [Related]

  • 11. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE, GL601 Study Group.
    Arthritis Rheum; 2002 Jul 15; 46(7):1820-9. PubMed ID: 12124866
    [Abstract] [Full Text] [Related]

  • 12. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K, Abeles M.
    J Rheumatol; 1994 Sep 15; 21(9):1674-7. PubMed ID: 7799348
    [Abstract] [Full Text] [Related]

  • 13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A, Tan E, Ilchyshyn A, Berth-Jones J.
    Br J Dermatol; 2006 Jun 15; 154(6):1169-74. PubMed ID: 16704650
    [Abstract] [Full Text] [Related]

  • 14. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM, Sato EI, Andrade LE, Ferraz MB, Atra E.
    Lupus; 1996 Jun 15; 5(3):237-41. PubMed ID: 8803897
    [Abstract] [Full Text] [Related]

  • 15. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM, Lan JL, Lin HY, Luo SF.
    Arthritis Rheum; 2002 Nov 15; 46(11):2924-7. PubMed ID: 12428233
    [Abstract] [Full Text] [Related]

  • 16. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE.
    Arthritis Rheum; 2001 Jun 15; 44(6):1351-8. PubMed ID: 11407694
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS.
    N Engl J Med; 1992 Apr 16; 326(16):1043-9. PubMed ID: 1549149
    [Abstract] [Full Text] [Related]

  • 18. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.
    Arthritis Rheum; 2005 Jan 16; 52(1):27-35. PubMed ID: 15641102
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct 16; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 20. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
    Kalunian KC, Davis JC, Merrill JT, Totoritis MC, Wofsy D, IDEC-131 Lupus Study Group.
    Arthritis Rheum; 2002 Dec 16; 46(12):3251-8. PubMed ID: 12483729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.